Kevin Sullivan

Past Chairperson

CEO – 3D BioFibR Inc.

Kevin Sullivan is a highly accomplished executive. He holds a Bachelor of Science degree in Microbiology & Immunology from Dalhousie University and a Master of Business Administration from the Richard Ivey School of Business at the University of Western Ontario.

Throughout his career, Sullivan has held several key leadership positions in various biotech companies. He is currently the CEO of 3D BioFibR Inc., and the previous CEO at Appili Therapeutics Inc., and DeNovaMed Inc. Additionally, he has held the positions of Chief Operating Officer and Vice President of Business Development at Viron Therapeutics Inc. He is highly regarded for his ability to introduce innovative therapeutic approaches into clinical settings and has a remarkable track record of successful fundraising, having raised over $90 million in equity, debt, and non-dilutive financing for both public and private companies.

Sullivan’s career has been focused on the commercialization of life-science technologies, with a particular emphasis on protein-based therapeutics, small molecule therapies, vaccines, and novel biomaterials.